Zydus Cadila gets USFDA approval to market 2 drugs
Zydus Cadila has received final approval to market two drugs, from the US health regulator. The company stated that, it has received approval to market Methylprednisolone tablets USP...
Tag : USFDA
Lupin gets USFDA approval to market Tetrabenazine tablets
Lupin has received final approval to market its Tetrabenazine tablets, from the US health regulator. It is used for treating involuntary movements associated with Huntington’s disease....
USFDA completes Unichem’s Ghaziabad plant inspection
The US health regulator has completed the inspection of Unichem’s Laboratories, Ghaziabad facility in Uttar Pradesh and the regulator has not issued any observation to it....
Glenmark gets USFDA nod for generic version of Temovate Topical
Glenmark Pharmaceuticals has received final approval for generic version of Temovate Topical Solution, from the US health regulator. It is used to treat certain scalp and skin...
Zydus gets USFDA approval to market Diclofenac Sodium Topical Solution
Zydus Cadila has received final approval to market Diclofenac Sodium Topical Solution, from the US health regulator. It is used for treating signs and symptoms of osteoarthritis of...
Glenmark gets USFDA approval for skin ointment
Glenmark Pharmaceuticals has received final approval for Tacrolimus ointment, from the US health regulator. The ointment is used for treating atopic dermatitis (eczema). In a BSE...
Strides Shasun gets USFDA nod for antihistamine drug
Strides Shasun’s wholly owned subsidiary Strdies Pharma Global Pte Ltd, has received approval for antihistamine drug, from the US health regulator. Cyproheptadine is an antihistamine used...
Dr Reddy gets EIR for Cuernavaca plant in Mexico from USFDA
Dr Reddy’s Laboratories has received establishment inspection report for its Cuernavaca facility in Mexico, from the US health regulator. In a filing to BSE the company...
Lupin gets EIR for Pithampur unit, from USFDA
Lupin has received the establishment investigation report (EIR) for the successful inspection of its Pithampur, Unit 1, from USFDA. The inspection was carried out during July...
Galaxy Surfactants receives 13 observations from USFDA, for Tarapur unit
Galaxy Surfactants has received Form 483, for two of its facilities situated at Tarapur, Maharashtra. The company’s two of the facilities (M3 & N46) at...